Evidence map›Paper›PMID 40903734›Full record

ArticleBMC nephrology2025

A rare case of dual glomerular pathology: Alport syndrome and immune complex-mediated MPGN.

Seyda Gul Ozcan, Eylul Koc, Ahmet Murt, Mevlut Tamer Dincer, Iclal Gurses, Nurhan Seyahi, Sinan Trabulus

Abstract readCase Reports
In one paragraph

Article in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Seyda Gul OzcanCerrahpasa Medical Faculty, Division of Nephrology, Istanbul University-Cerrahpasa, Istanbul, Turkey. seydagulozcan@gmail.com.
Eylul KocCerrahpasa Medical Faculty, Department of Internal Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Ahmet MurtCerrahpasa Medical Faculty, Division of Nephrology, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Mevlut Tamer DincerCerrahpasa Medical Faculty, Division of Nephrology, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Iclal GursesCerrahpasa Medical Faculty, Department of Pathology, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Nurhan SeyahiCerrahpasa Medical Faculty, Division of Nephrology, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Sinan TrabulusCerrahpasa Medical Faculty, Division of Nephrology, Istanbul University-Cerrahpasa, Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundImmune complex-mediated membranoproliferative glomerulonephritis (IC-MPGN) and Alport syndrome are distinct glomerular diseases with different pathophysiologic mechanisms. Their coexistence is extremely rare and may present diagnostic and therapeutic challenges. CASE PRESENTATION: A 42-year-old woman presented with persistent proteinuria and hematuria. Initial laboratory evaluations showed a progressive increase in proteinuria. She had a family history of renal disease. A renal biopsy, which had initially been postponed on patient request, subsequently revealed diffuse mesangial and focal endocapillary proliferation, GBM thickening, periglomerular fibrosis, and immune complex deposition with IgM, C3, and C1q, thereby confirming the diagnosis of IC-MPGN. Genetic testing identified a heterozygous COL4A5 c.1871G > A (p.Gly624Asp) mutation consistent with X-linked Alport syndrome. The patient follows conservative management now.

conclusionThis case highlights the rare coexistence of IC-MPGN, chronic TIN and Alport syndrome. In patients with progressive glomerular disease, especially with a family history of renal disease or extrarenal findings, genetic evaluation should be considered. Early renal biopsy and genetic testing are essential to guide management in complex cases with overlapping features.

Indexed as

Glomerulonephritis, MembranoproliferativeImmune Complex DiseasesKidney GlomerulusNephritis, HereditaryAdultCollagen Type IVFemaleHumansCOL4A5 protein, humanCollagen Type IVAlport syndromeGenetic kidney diseaseImmune complex mediated MPGN

Identifiers

PMID40903734
PMCPMC12409941

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.